Aayush Wellness share price traded marginally lower by 0.16% at ₹36.45 on Friday, despite the company's strategic expansion announcement. According to latest market reports, the Indian equity markets traded lower with the benchmark Nifty 50 index declining by 0.58% to 24,186.15 during the session. However, stock-specific action remained visible in select microcap healthcare and wellness counters after business expansion announcements, with Aayush Wellness remaining in focus after the company's strategic entry into India's metabolic health and preventive wellness market.
Integrated healthcare and preventive wellness company Aayush Wellness announced its strategic entry into the diabetes and metabolic health sector with the launch of 'Aayush Dia Shield Tablets'. As reported by Stock Market News, the launch positions the company within the high-growth ₹366.56 billion metabolic health market. The company stated that the science-backed dietary supplement is designed to support long-term blood sugar management and preventive healthcare needs. The product formulation includes herbal extracts such as Fenugreek (Methi), Karela, Gurmar and Cinnamon Bark Extract, which are traditionally associated with metabolic and glucose management benefits.
The launch strengthens Aayush Wellness' healthcare portfolio and positions the company within India's rapidly growing diabetes and preventive healthcare segment. According to the company, India currently has over 100 million people living with diabetes and another 136 million individuals categorised as pre-diabetic. The company added that nearly 50% of diabetes cases remain undiagnosed, with prevalence increasing rapidly among working professionals aged between 30 and 45 years. Managing Director Naveena Kumar stated that the company aims to strengthen its preventive healthcare portfolio in line with evolving consumer wellness trends and long-term growth opportunities in the healthcare sector.
According to Stock Market News, Aayush Wellness has delivered exceptional long-term returns despite recent volatility. The stock has jumped 99% in two years and has surged by a staggering 1,825% over the past three years. However, the stock has fallen 43% on a year-to-date basis and has declined 63% in one year, reflecting recent market challenges. The company is an India-based preventive healthcare and wellness company established in 1984, focusing on nutraceutical, wellness and preventive healthcare offerings aimed at supporting healthier lifestyle choices.
